Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Ruggiero

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Journal of the American Society of Nephrology : JASN|November 15, 2015
B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic SyndromeManuela Colucci, Rita Carsetti, Simona Cascioli, et al.
Kidney & Blood Pressure Research|June 20, 2024
RRAGD-Associated Autosomal Dominant Kidney Hypomagnesemia with Cardiomyopathy: A Review on the Clinical Manifestations and Therapeutic OptionsFrancesco Trepiccione, Irene Sambri, Barbara Ruggiero, et al.
Journal of the American Society of Nephrology : JASN|July 24, 2012
Rituximab in idiopathic membranous nephropathyPiero Ruggenenti, Paolo Cravedi, Antonietta Chianca, et al.
Pediatric Nephrology (Berlin, Germany)|October 7, 2020
IgM on the surface of T cells: a novel biomarker of pediatric-onset systemic lupus erythematosusManuela Colucci, Barbara Ruggiero, Alessandra Gianviti, et al.
European Journal of Endocrinology|April 21, 2026
Impact of diagnosis and targeted interventions on the quality of life and neuropsychiatric outcomes of patients with adrenal tumours: a systematic reviewBarbara Ruggiero, Giuliana Zhu, Liam Swan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 9, 2016
Outcome of childhood-onset full-house nephropathyBarbara Ruggiero, Marina Vivarelli, Alessandra Gianviti, et al.
Frontiers in Immunology|January 5, 2026
Prolonged impairment of immunological memory after anti-CD20 treatment in pediatric idiopathic nephrotic syndrome: an extended follow-upManuela Colucci, Martina Riganati, Federica Zotta, et al.
International Journal of Molecular Sciences|May 13, 2023
Immunophenotypic Alterations in Adult Patients with Steroid-Dependent and Frequently Relapsing Nephrotic SyndromeFederica Casiraghi, Marta Todeschini, Manuel Alfredo Podestà, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 27, 2023
Anti-Phospholipase A2 Receptor 1 and Anti-Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort StudyPiero Ruggenenti, Linda Reinhard, Barbara Ruggiero, et al.
Journal of the American Society of Nephrology : JASN|March 26, 2015
Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous NephropathyPiero Ruggenenti, Hanna Debiec, Barbara Ruggiero, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Journal of the American Society of Nephrology : JASN|November 15, 2015
B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic SyndromeManuela Colucci, Rita Carsetti, Simona Cascioli, et al.
Kidney & Blood Pressure Research|June 20, 2024
RRAGD-Associated Autosomal Dominant Kidney Hypomagnesemia with Cardiomyopathy: A Review on the Clinical Manifestations and Therapeutic OptionsFrancesco Trepiccione, Irene Sambri, Barbara Ruggiero, et al.
Journal of the American Society of Nephrology : JASN|July 24, 2012
Rituximab in idiopathic membranous nephropathyPiero Ruggenenti, Paolo Cravedi, Antonietta Chianca, et al.
Pediatric Nephrology (Berlin, Germany)|October 7, 2020
IgM on the surface of T cells: a novel biomarker of pediatric-onset systemic lupus erythematosusManuela Colucci, Barbara Ruggiero, Alessandra Gianviti, et al.
European Journal of Endocrinology|April 21, 2026
Impact of diagnosis and targeted interventions on the quality of life and neuropsychiatric outcomes of patients with adrenal tumours: a systematic reviewBarbara Ruggiero, Giuliana Zhu, Liam Swan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 9, 2016
Outcome of childhood-onset full-house nephropathyBarbara Ruggiero, Marina Vivarelli, Alessandra Gianviti, et al.
Frontiers in Immunology|January 5, 2026
Prolonged impairment of immunological memory after anti-CD20 treatment in pediatric idiopathic nephrotic syndrome: an extended follow-upManuela Colucci, Martina Riganati, Federica Zotta, et al.
International Journal of Molecular Sciences|May 13, 2023
Immunophenotypic Alterations in Adult Patients with Steroid-Dependent and Frequently Relapsing Nephrotic SyndromeFederica Casiraghi, Marta Todeschini, Manuel Alfredo Podestà, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 27, 2023
Anti-Phospholipase A2 Receptor 1 and Anti-Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort StudyPiero Ruggenenti, Linda Reinhard, Barbara Ruggiero, et al.
Journal of the American Society of Nephrology : JASN|March 26, 2015
Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous NephropathyPiero Ruggenenti, Hanna Debiec, Barbara Ruggiero, et al.
Pageof 4